Neuralink, Elon Musk's neurotechnology company, has achieved a significant milestone by receiving Breakthrough Device ...

The company said that its applications can be extended to individuals affected by ALS, stroke, spinal cord injury, cerebral ...

Patent estate covering atrioventricular interval modulation (“AVIM”) therapy now includes 46 issued U.S. patents and 91 patents outside the U.S. that collectively comprise over 2100 claims related to ...

The FDA designation is a step forward for Neuralink as owner Elon Musk faces increasing scrutiny. The US Food and Drug ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

CHENNAI: It’s nothing but the dance of mind and machine, where neurons whisper secrets and wires weave dreams. As the digital ...

Elon Musk's neurotechnology company Neuralink announced on Thursday (1 May) that it has received the US Food and Drug ...

Smith is the first non-verbal individual and only the third person globally to receive a Neuralink Brain-Chip Interface (BCI) implant.